Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CYTOKINE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | CYTOKINE |
| Key Genes/Proteins | ABL1, AMYLOID, amyotrophic lateral sclerosis, ANXIETY |
| Related Diseases | aging, Alzheimer'S Disease |
graph TD
CYTOKINE["CYTOKINE"]
CYTOKINE ---|"co-discussed"| MITOCHONDRIA["MITOCHONDRIA"]
CYTOKINE ---|"co-discussed"| TDP_43["TDP-43"]
CYTOKINE ---|"co-discussed"| ER_STRESS["ER STRESS"]
CYTOKINE ---|"co-discussed"| IL6["IL6"]
CYTOKINE ---|"co-discussed"| OCLN["OCLN"]
CYTOKINE ---|"co-discussed"| MICROGLIA["MICROGLIA"]
ALS["ALS"] ---|"co-discussed"| CYTOKINE
CLDN5["CLDN5"] ---|"co-discussed"| CYTOKINE
AUTOPHAGY["AUTOPHAGY"] ---|"co-discussed"| CYTOKINE
COMPLEMENT["COMPLEMENT"] ---|"co-discussed"| CYTOKINE
APOPTOSIS["APOPTOSIS"] ---|"co-discussed"| CYTOKINE
AKT["AKT"] ---|"co-discussed"| CYTOKINE| Target | Relation | Type | Str |
|---|---|---|---|
| Aging | inhibits | disease | 0.60 |
| Parkinson | activates | disease | 0.60 |
| Leukemia | activates | disease | 0.60 |
| Neurodegeneration | biomarker_for | disease | 0.60 |
| Neuroinflammation | biomarker_for | disease | 0.60 |
| Cancer | activates | disease | 0.60 |
| Neuropathy | causes | disease | 0.60 |
| Neurodegeneration | therapeutic_target | disease | 0.60 |
| Autism | expressed_in | disease | 0.60 |
| Diabetes | activates | disease | 0.60 |
| Fibrosis | activates | disease | 0.60 |
| Glioblastoma | activates | disease | 0.60 |
| Ischemia | associated_with | disease | 0.60 |
| Aging | causes | disease | 0.60 |
| Obesity | activates | disease | 0.60 |
| Cancer | causes | disease | 0.60 |
| Frontotemporal Dementia | therapeutic_target | disease | 0.60 |
| Depression | interacts_with | disease | 0.60 |
| Lymphoma | phosphorylates | disease | 0.60 |
| Dementia | therapeutic_target | disease | 0.60 |
| Amyotrophic Lateral Sclerosis | therapeutic_target | disease | 0.60 |
| Atherosclerosis | expressed_in | disease | 0.60 |
| Neuroinflammation | causes | disease | 0.60 |
| Migraine | activates | disease | 0.60 |
| Neurodegeneration | inhibits | disease | 0.60 |
| Multiple Sclerosis | inhibits | disease | 0.60 |
| Alzheimer | associated_with | disease | 0.60 |
| Retinopathy | therapeutic_target | disease | 0.60 |
| Retinopathy | activates | disease | 0.60 |
| Encephalitis | associated_with | disease | 0.60 |
| Parkinson | expressed_in | disease | 0.60 |
| Autism | contributes_to | disease | 0.60 |
| Obesity | inhibits | disease | 0.60 |
| Multiple Sclerosis | regulates | disease | 0.60 |
| Schizophrenia | regulates | disease | 0.60 |
| Stroke | activates | disease | 0.60 |
| Atherosclerosis | therapeutic_target | disease | 0.60 |
| Encephalitis | activates | disease | 0.60 |
| Pyroptosis | expressed_in | disease | 0.60 |
| Pyroptosis | inhibits | disease | 0.60 |
| Depression | regulates | disease | 0.60 |
| Neurodegeneration | regulates | disease | 0.60 |
| Aging | protects_against | disease | 0.60 |
| Obesity | regulates | disease | 0.60 |
| Stroke | inhibits | disease | 0.60 |
| Stroke | interacts_with | disease | 0.60 |
| Neuroinflammation | associated_with | disease | 0.60 |
| Depression | associated_with | disease | 0.60 |
| Als | activates | disease | 0.60 |
| Aging | regulates | disease | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| MICROGLIA | regulates | gene | 0.60 |
| IL-4 | inhibits | gene | 0.60 |
| CLDN5 | inhibits | gene | 0.60 |
| HIF1 | regulates | gene | 0.60 |
| BMAL1 | activates | gene | 0.60 |
| IL-13 | inhibits | gene | 0.60 |
| RNA | therapeutic_target | gene | 0.60 |
| PPP1R15A | therapeutic_target | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| HV1 | regulates | gene | 0.60 |
| HIPPO | activates | gene | 0.60 |
| CRY1 | activates | gene | 0.60 |
| DEPRESSION | activates | gene | 0.60 |
| NRF2 | inhibits | gene | 0.60 |
| ATF4 | therapeutic_target | gene | 0.60 |
| HSPA5 | therapeutic_target | gene | 0.60 |
| XBP1 | therapeutic_target | gene | 0.60 |
| IL23A | inhibits | gene | 0.60 |
| DNA | expressed_in | gene | 0.60 |
| PKM2 | inhibits | gene | 0.60 |
| HK2 | inhibits | gene | 0.60 |
| IL-6 | inhibits | gene | 0.60 |
| HK2 | regulates | gene | 0.60 |
| HEDGEHOG | activates | gene | 0.60 |
| IL-6 | activates | gene | 0.60 |
| ICAM1 | activates | gene | 0.60 |
| TNFRSF1A | activates | gene | 0.60 |
| OCLN | activates | gene | 0.60 |
| ANXIETY | activates | gene | 0.60 |
| IBA1 | activates | gene | 0.60 |
| IL6 | inhibits | gene | 0.60 |
| CXCL1 | inhibits | gene | 0.60 |
| DDIT3 | therapeutic_target | gene | 0.60 |
| IRE1 | therapeutic_target | gene | 0.60 |
| IL12B | inhibits | gene | 0.60 |
| OCLN | inhibits | gene | 0.60 |
| PERK | therapeutic_target | gene | 0.60 |
| CYTOKINES | inhibits | gene | 0.60 |
| CNO | biomarker_for | gene | 0.60 |
| ALZHEIMER | biomarker_for | gene | 0.60 |
| APOPTOSIS | expressed_in | gene | 0.60 |
| NUCLEOLIN | expressed_in | gene | 0.60 |
| PFKFB3 | inhibits | gene | 0.60 |
| SPR | inhibits | gene | 0.60 |
| LDHA | inhibits | gene | 0.60 |
| IL-1 | inhibits | gene | 0.60 |
| RNA | regulates | gene | 0.60 |
| PFKFB3 | regulates | gene | 0.60 |
| SIRT1 | activates | gene | 0.60 |
| STAT6 | inhibits | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Astrocyte-Microglia Communication Rebalancing via Cytokine M | 0.655 | neurodegeneration | Which cell types show the most significa |
| Mitochondrial-Cytokine Axis Modulation | 0.532 | neurodegeneration | Gene expression changes in aging mouse b |
| Closed-loop neuromodulation-inspired cytokine axis suppressi | 0.530 | cell-biology | - |
| Temporal Cytokine Receptor Modulation | 0.455 | chronobiology | Can circadian interventions reverse micr |
| Compensatory Cytokine Network Activation | 0.455 | clinical-neurology | Why do systemic anti-inflammatory drugs |
| Microglial State-Dependent Cytokine Function | 0.455 | clinical-neurology | Why do systemic anti-inflammatory drugs |
| CNS-Peripheral Cytokine Compartmentalization | 0.455 | clinical-neurology | Why do systemic anti-inflammatory drugs |
| STAT3 Epigenetic Priming as Mechanism of Peripheral Cytokine | 0.347 | immunomics | Systemic immune profiling in neurodegene |
| Temporal Cytokine Window Therapeutic Intervention | 0.000 | - | Blood-brain barrier tight junction disru |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| LPS-induced mouse model of depression with synaptic loss analysis | validation | depression | 0.900 | 0.00 | LPS-treated mice | proposed | N/A |
| Network pharmacology analysis of QTJD active compounds and pathways | exploratory | Mycoplasma pneumoniae pneumoni | 0.900 | 0.00 | computational network analysis | proposed | N/A |
| Bidirectional Mendelian randomization analysis of C1Q and ischemic str | exploratory | Ischemic stroke, Atheroscleros | 0.900 | 0.00 | Human genetic association data | proposed | N/A |
| Bidirectional Mendelian randomization analysis of C1Q and ischemic str | exploratory | Ischemic stroke (large artery | 0.900 | 0.00 | human genetic data | proposed | N/A |
| C1q neutralizing antibody intervention in depression model | validation | depression | 0.850 | 0.00 | LPS-treated mice with C1q anti | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning CYTOKINE in their description or question text
Score: 0.455 · clinical-neurology · 2026-04-27
TNF-α and IL-6 serve protective functions in homeostatic microglia but become pathogenic in disease-associated microglia
Score: 0.455 · clinical-neurology · 2026-04-27
The blood-brain barrier creates distinct cytokine microenvironments where peripheral TNF-α/IL-6 inhibition fails to reac
Score: 0.347 · immunomics · 2026-04-25
STAT3 Epigenetic Priming as Mechanism of Peripheral Cytokine Memory
Score: 0.000 · unknown disease · 2026-04-28
Sequential IL-1β receptor antagonist treatment followed by Wnt pathway activation targeting the 6-24 hour post-injury wi